Iopromide

CHEMBL1725 Phase 4 معتمد Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
791.1 g/mol
LogP
-2.1
Phase
4

This non-ionic, low-osmolality iodinated contrast agent is used for CT scans, angiography, urography, and other diagnostic imaging procedures. It reduces X-ray transparency in the tissues and blood vessels it passes through, improving the visibility of structures. Its low osmolality profile is associated with good tolerability and lower risk of adverse reactions.

الوزن الجزيئي

791,1000 g/mol

LogP

-2,10

TPSA

169,00 Ų

قاعدة ليبينسكي للخمسة

راسب

المجالات العلاجية

آلية العمل

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

الآلية

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

البنية ثنائية الأبعاد

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I

InChI

InChI=1S/C18H24I3N3O8/c1-24(4-9(28)6-26)18(31)12-13(19)11(17(30)22-3-8(27)5-25)14(20)16(15(12)21)23-10(29)7-32-2/h8-9,25-28H,3-7H2,1-2H3,(H,22,30)(H,23,29)

Molecular Formula

C18H24I3N3O8

HBD / HBA

6 / 8

الروابط القابلة للدوران

11

الذرات الثقيلة

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

الأسئلة الشائعة

This non-ionic, low-osmolality iodinated contrast agent is used for CT scans, angiography, urography, and other diagnostic imaging procedures. It reduces X-ray transparency in the tissues and blood vessels it passes through, improving the visibility of structures. Its low osmolality profile is associated with good tolerability and lower risk of adverse reactions.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Iopromide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1725. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3736. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

إخلاء المسؤولية الطبية

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.